HCA HCA Healthcare, Inc. Common Stock
Про HCA Healthcare, Inc. Common Stock Огляд компанії з Wikipedia
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
Детальніше
HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
History
Early years
The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.
The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.
Growth and merger
The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.
In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.
In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,
to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.
Columbia Hospital Corporation
In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.
In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.
Recent history
On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.
In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.
In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.
In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.
In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.
In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.
In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.
In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.
Facilities
United States
As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.
Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.
In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.
In 2019 they purchased Mission Health System which operates hospitals in North Carolina.
In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.
In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.
United Kingdom
HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:
It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.
The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.
The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.
Significant areas of operation
Medical education
In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.
Controversies
Medicare billing practices lawsuit
In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.
The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.
2005 insider trading suit
In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.
COVID-19 PPE
During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.
Mission Hospital Acquisition Complaints
On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.
On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.
Джерело: Wikipedia (Англійська), CC BY-SA 4.0 · Переглянути на Wikipedia ↗
HCA Знімок акцій Ціна, ринкова капіталізація, P/E, EPS, ROE, борг/власний капітал, діапазон 52 тижнів
HCA Графік ціни акцій Денні OHLCV з технічними індикаторами — панування, масштабування та налаштування вашого представлення
10-річна ефективність Тренди виручки, чистого прибутку, маржі та EPS
Оцінка Співвідношення P/E, P/S, P/B, EV/EBITDA — акція дорога чи дешева?
Прибутковість Валова, операційна та чиста маржа; ROE, ROA, ROIC
Фінансове здоровʼя Борг, ліквідність, платоспроможність — міцність балансу
Зростання Зростання виручки, EPS та чистого прибутку: рік до року, 3-річний CAGR, 5-річний CAGR
Ефективність капіталу Оборотність активів, оборотність запасів, оборотність дебіторської заборгованості
Дивіденди Дивідендна дохідність, коефіцієнт виплат, історія дивідендів, 5-річний CAGR
| Дата екс-дивіденду | Сума |
|---|---|
| 16 червня 2026 р. | $0,7800 |
| 17 березня 2026 р. | $0,7800 |
| 15 грудня 2025 р. | $0,7200 |
| 16 вересня 2025 р. | $0,7200 |
| 16 червня 2025 р. | $0,7200 |
| 17 березня 2025 р. | $0,7200 |
| 13 грудня 2024 р. | $0,6600 |
| 16 вересня 2024 р. | $0,6600 |
| 14 червня 2024 р. | $0,6600 |
| 14 березня 2024 р. | $0,6600 |
| 13 грудня 2023 р. | $0,6000 |
| 14 вересня 2023 р. | $0,6000 |
| 15 червня 2023 р. | $0,6000 |
| 16 березня 2023 р. | $0,6000 |
| 13 грудня 2022 р. | $0,5600 |
| 15 вересня 2022 р. | $0,5600 |
| 15 червня 2022 р. | $0,5600 |
| 16 березня 2022 р. | $0,5600 |
| 13 грудня 2021 р. | $0,4800 |
| 15 вересня 2021 р. | $0,4800 |
HCA Консенсус аналітиків Бичачі та ведмежі думки аналітиків, 12-місячна цільова ціна, потенціал зростання
- Активна купівля 6 20,0%
- Купівля 11 36,7%
- Утримувати 12 40,0%
- Продаж 1 3,3%
- Активний продаж 0 0,0%
12-місячна цільова ціна
21 аналітиків · 2026-08-17Історія прибутків EPS фактичний проти прогнозу, сюрприз %, коефіцієнт перевищення, дата наступного звіту про прибутки
| Період | EPS Actual | EPS прогноз | Сюрприз |
|---|---|---|---|
| 30 червня 2026 р. | $7.62 | $7.54 | 0.08% |
| 31 березня 2026 р. | $7.15 | $7.21 | -0.06% |
| 31 грудня 2025 р. | $8.14 | $7.53 | 0.61% |
| 30 вересня 2025 р. | $6.96 | $5.77 | 1.2% |
| 30 червня 2025 р. | $6.83 | $6.31 | 0.52% |
| 31 березня 2025 р. | $6.45 | $5.84 | 0.61% |
Порівняння з аналогами (підгалузь GICS) Ключові показники порівняно з аналогами в секторі
| Тікер | Капіталізація | P/E | Виручка рік до року | Чиста маржа | ROE | Валова маржа |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | — |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | — |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | — |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | — |
| UHS | — | 9.4 | 9.7% | 8.6% | 21.4% | — |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | — |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | — |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | — |
| SGRY | $2.00B | -25.3 | 6.2% | -2.4% | -4.5% | — |
Повні фундаментальні показники Усі показники за роками — звіт про прибутки та збитки, баланс, рух грошових коштів
Звіт про прибутки та збитки 12
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
Баланс 22
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
Грошовий потік 17
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
Прибутковість 5
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
Ліквідність та платоспроможність 4
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
Ефективність 2
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
Темпи зростання 10
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
Оцінка (TTM) 17
| Метрика | Тенденція | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
Звіт про прибутки та збитки 12
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | -482,587,000 | 232,891,000 | 239,173,000 | 246,936,000 | -523,751,000 | 256,763,000 | 261,156,000 | 264,435,000 | -550,173,000 | 271,173,000 | 274,494,000 | 276,910,000 | -590,583,000 | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | -488,037,000 | 236,181,000 | 241,911,000 | 249,440,000 | -530,198,000 | 259,917,000 | 264,071,000 | 268,016,000 | -558,171,000 | 275,424,000 | 278,198,000 | 280,961,000 | -598,621,000 | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
Баланс 20
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
Грошовий потік 16
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
Прибутковість 5
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
Ліквідність та платоспроможність 4
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
Ефективність 2
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
Оцінка (TTM) 14
| Метрика | Тенденція | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $77.11B | $75.20B | · | $73.57B | $71.91B | $70.64B | · | $68.53B | $66.91B | $65.00B | · | $62.64B | $61.24B | $60.33B | · | $60.01B | |
| Net Income TTM | $6.62B | $6.53B | · | $6.18B | $5.99B | $5.93B | · | $5.40B | $5.32B | $5.23B | · | $4.77B | $4.84B | $4.92B | · | $5.83B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.7 | 17.3 | · | 17.0 | 16.2 | 15.2 | · | 20.1 | 16.3 | 17.6 | · | 14.5 | 17.9 | 15.7 | · | 9.7 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.3 | 1.2 | · | 1.5 | 1.2 | 1.4 | · | 1.1 | 1.4 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| P / FCF | · | 117.7 | · | · | · | 127.2 | · | · | · | 65.0 | · | · | · | 120.1 | · | · | |
| EV / EBITDA | 135.0 | 154.7 | · | 152.3 | 149.4 | 148.2 | · | 170.5 | 150.6 | 159.4 | · | 136.0 | 158.5 | 146.5 | · | 118.7 | |
| EV / FCF | · | 160.7 | · | · | · | 193.1 | · | · | · | 93.8 | · | · | · | 182.8 | · | · | |
| EV / Revenue | 1.7 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Earnings Yield | 7.3% | 5.8% | · | 5.9% | 6.2% | 6.6% | · | 5.0% | 6.1% | 5.7% | · | 6.9% | 5.6% | 6.4% | · | 10.3% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · |
Фінансова звітність Звіт про прибутки та збитки, баланс, рух грошових коштів — річні, за останні 5 років
Звіт про прибутки та збитки
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Виручка | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| Чистий прибуток | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| Розбавлений EPS | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
Баланс
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Борг / Власний капітал | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| Поточний коефіцієнт | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| Коефіцієнт швидкої ліквідності | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
Грошовий потік
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Вільний грошовий потік | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
Останні новини Останні заголовки, що згадують цю компанію
- Could HCA Healthcare, Inc. (HCA) Stock Rebound After Guidance Cuts and Payer Pressure?
- Bernstein Remains Bullish On HCA Healthcare (HCA); Projects EBITDA Growth Of 2.8% and 4.6% in 2026 And 2027
- HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
- Визначна опціонна активність у четвер: HCA, HRTG, ZM
- Стратегія фінансування HCA Healthcare (HCA) розширюється – ось як
- HCA Healthcare перевищила квартальні прогнози прибутку на тлі попиту на медичне обслуговування
Мої показники Ваш персональний список спостереження — вибрані рядки з Повних фундаментальних даних
Виберіть показники, які для вас важливі — натисніть ➕ поруч із будь-яким рядком у Повних фундаментальних даних вище.
Ваш вибір збережено і він буде застосовуватися до всіх тікерів.
Інституційні власники (13F) 1 486 подавачів звітності · $39.4B всього · Станом на 30 червня 2026 р.
Інституційні інвестори, які звітують про володіння цими акціями у своїй квартальній формі SEC 13F. Тільки довгі позиції; один подавець звітності може з'явитися двічі для окремих опціонних контрактів. Великі протилежні опціонні позиції (пут/кол) зазвичай відображають маркет-мейкінг або хеджування запасів, а не спрямованість переконань.
| Нові позиції | Закриті позиції | Збільшено | Зменшено | Зміна чистих акцій |
|---|---|---|---|---|
| 128 (-51 проти попереднього кв.) | 174 (+70 проти попереднього кв.) | 450 (-30 проти попереднього кв.) | 555 (-4 проти попереднього кв.) | +16.3M |
Порівняно з Q1 2026. Звіти SEC Form 13F подаються протягом 45 днів після закінчення кварталу плюс невеликий буфер для тих, хто подає із запізненням — квартали, що ще знаходяться в цьому вікні, пропускаються на користь останньої повністю звітної пари.
| Інституційний інвестор | Вартість | Акції | % від відстежуваного 13F | Тип |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6 118 113 464 | 13 104 814 | 15,52% | Акції |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 954 150 533 | 10 141 708 | 10,03% | Акції |
| Sanders Capital, LLC | $3 442 060 818 | 8 828 287 | 8,73% | Акції |
| STATE STREET CORP | $2 912 102 056 | 7 469 035 | 7,39% | Акції |
| WELLINGTON MANAGEMENT GROUP LLP | $1 750 298 867 | 4 489 212 | 4,44% | Акції |
| GEODE CAPITAL MANAGEMENT, LLC | $1 225 259 672 | 3 159 159 | 3,11% | Акції |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 057 704 509 | 2 712 828 | 2,68% | Акції |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861 456 107 | 2 209 485 | 2,19% | Акції |
| NORGES BANK | $836 457 140 | 2 145 367 | 2,12% | Акції |
| Capital World Investors | $770 864 224 | 1 977 121 | 1,96% | Акції |
| Capital International Investors | $747 403 041 | 1 916 947 | 1,90% | Акції |
| Crake Asset Management LLP | $449 072 183 | 1 151 792 | 1,14% | Акції |
| Metropolis Capital Ltd | $430 915 307 | 910 564 | 1,09% | Акції |
| Darsana Capital Partners LP | $428 879 000 | 1 100 000 | 1,09% | Акції |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414 533 777 | 1 063 207 | 1,05% | Акції |
| Life Cycle Investment Partners Ltd | $355 737 196 | 912 404 | 0,90% | Акції |
| VANGUARD FIDUCIARY TRUST CO | $339 685 814 | 871 235 | 0,86% | Акції |
| FMR LLC | $325 199 295 | 834 080 | 0,83% | Акції |
| BARCLAYS PLC | $299 888 573 | 769 162 | 0,76% | Акції |
| LYRICAL ASSET MANAGEMENT LP | $255 015 742 | 654 071 | 0,65% | Акції |
| BlackRock, Inc. | $240 062 291 | 615 718 | 0,61% | Акції |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235 649 908 | 604 401 | 0,60% | Акції |
| National Pension Service | $230 650 346 | 591 578 | 0,59% | Акції |
| NORDEA INVESTMENT MANAGEMENT AB | $230 189 125 | 594 466 | 0,58% | Акції |
| GOLDMAN SACHS GROUP INC | $209 775 669 | 538 038 | 0,53% | Акції |
| Gobi Capital LLC | $195 742 325 | 502 045 | 0,50% | Акції |
| Cryder Capital Partners LLP | $194 561 738 | 499 017 | 0,49% | Акції |
| Swiss National Bank | $172 097 446 | 441 400 | 0,44% | Акції |
| AustralianSuper Pty Ltd | $159 635 782 | 409 438 | 0,41% | Акції |
| Consulta Ltd | $155 956 000 | 400 000 | 0,40% | Акції |
| LEE DANNER & BASS INC | $152 150 679 | 390 240 | 0,39% | Акції |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $151 472 265 | 388 500 | 0,38% | Опціон кол |
| Mitsubishi UFJ Asset Management Co., Ltd. | $147 943 761 | 379 450 | 0,38% | Акції |
| DIMENSIONAL FUND ADVISORS LP | $139 697 405 | 358 300 | 0,35% | Акції |
| Vanguard Global Advisers, LLC | $136 962 509 | 351 285 | 0,35% | Акції |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $134 838 505 | 288 820 | 0,34% | Акції |
| ALLIANCEBERNSTEIN L.P. | $134 459 788 | 284 126 | 0,34% | Акції |
| Sumitomo Mitsui Trust Group, Inc. | $132 794 974 | 340 596 | 0,34% | Акції |
| TD Asset Management Inc | $131 847 152 | 338 165 | 0,33% | Акції |
| Legal & General Group Plc | $127 805 162 | 327 798 | 0,32% | Акції |
| California Public Employees Retirement System | $124 133 958 | 318 382 | 0,31% | Акції |
| LAZARD ASSET MANAGEMENT LLC | $120 619 879 | 309 369 | 0,31% | Акції |
| JANE STREET GROUP, LLC | $119 540 274 | 306 600 | 0,30% | Опціон кол |
| VANGUARD ASSET MANAGEMENT, Ltd | $116 069 863 | 297 699 | 0,29% | Акції |
| CAPTRUST FINANCIAL ADVISORS | $114 741 071 | 294 291 | 0,29% | Акції |
| ANTIPODES PARTNERS Ltd | $113 045 096 | 289 941 | 0,29% | Акції |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $109 718 328 | 231 845 | 0,28% | Акції |
| CITADEL ADVISORS LLC | $105 660 190 | 271 000 | 0,27% | Опціон кол |
| RHUMBLINE ADVISERS | $97 580 413 | 250 277 | 0,25% | Акції |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $97 026 076 | 248 855 | 0,25% | Акції |
| MACKENZIE FINANCIAL CORP | $93 597 383 | 240 061 | 0,24% | Акції |
| BloombergSen Inc. | $93 160 317 | 238 940 | 0,24% | Акції |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $92 247 974 | 236 600 | 0,23% | Опціон пут |
| Brandywine Global Investment Management, LLC | $89 380 814 | 191 451 | 0,23% | Акції |
| BANK OF AMERICA CORP /DE/ | $89 069 981 | 228 449 | 0,23% | Акції |
| NEUBERGER BERMAN GROUP LLC | $85 926 216 | 220 386 | 0,22% | Акції |
| MILFORD FUNDS LTD | $82 165 029 | 210 739 | 0,21% | Акції |
| Bridgewater Associates, LP | $79 227 208 | 203 204 | 0,20% | Акції |
| Prana Capital Management, LP | $75 552 494 | 193 779 | 0,19% | Акції |
| DANSKE BANK A/S | $73 238 497 | 187 844 | 0,19% | Акції |
| FRANKLIN RESOURCES INC | $70 965 828 | 182 015 | 0,18% | Акції |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $70 445 715 | 180 681 | 0,18% | Акції |
| Quantinno Capital Management LP | $70 407 055 | 180 581 | 0,18% | Акції |
| ARGENT CAPITAL MANAGEMENT LLC | $69 149 681 | 177 357 | 0,18% | Акції |
| Retirement Systems of Alabama | $68 081 812 | 174 618 | 0,17% | Акції |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $66 167 842 | 169 709 | 0,17% | Акції |
| BNP PARIBAS FINANCIAL MARKETS | $64 793 090 | 166 183 | 0,16% | Акції |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $64 665 206 | 165 855 | 0,16% | Акції |
| HSBC HOLDINGS PLC | $64 431 534 | 165 332 | 0,16% | Акції |
| AVIVA PLC | $64 264 789 | 164 828 | 0,16% | Акції |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $64 194 533 | 135 649 | 0,16% | Акції |
| SEB Asset Management AB | $63 257 255 | 162 244 | 0,16% | Акції |
| TODD ASSET MANAGEMENT LLC | $62 567 208 | 160 474 | 0,16% | Акції |
| Swedbank AB | $62 528 998 | 160 376 | 0,16% | Акції |
| W1M Investment Management Ltd | $61 247 490 | 143 647 | 0,16% | Акції |
| HARRIS ASSOCIATES L P | $60 080 879 | 154 097 | 0,15% | Акції |
| Ensign Peak Advisors, Inc | $58 372 381 | 149 715 | 0,15% | Акції |
| NEW YORK STATE COMMON RETIREMENT FUND | $57 747 778 | 148 113 | 0,15% | Акції |
| CITADEL ADVISORS LLC | $57 235 852 | 146 800 | 0,15% | Опціон пут |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $57 160 993 | 146 800 | 0,15% | Акції |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $56 512 217 | 144 944 | 0,14% | Акції |
| Pictet Asset Management Holding SA | $52 147 803 | 133 739 | 0,13% | Акції |
| VICTORY CAPITAL MANAGEMENT INC | $50 752 761 | 130 172 | 0,13% | Акції |
| Pentwater Capital Management LP | $50 685 700 | 130 000 | 0,13% | Акції |
| D. E. Shaw & Co., Inc. | $50 554 307 | 129 663 | 0,13% | Акції |
| APG Asset Management N.V. | $50 368 550 | 147 699 | 0,13% | Акції |
| AMF Tjanstepension AB | $50 355 853 | 129 154 | 0,13% | Акції |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $50 349 225 | 129 137 | 0,13% | Акції |
| EQUITABLE TRUST CO | $49 147 974 | 126 056 | 0,12% | Акції |
| ENVESTNET ASSET MANAGEMENT INC | $48 919 124 | 125 469 | 0,12% | Акції |
| CANADA PENSION PLAN INVESTMENT BOARD | $48 197 812 | 123 619 | 0,12% | Акції |
| AMERICAN CENTURY COMPANIES INC | $47 460 140 | 121 727 | 0,12% | Акції |
| OpenArc Corporate Advisory, LLC | $47 210 610 | 121 087 | 0,12% | Акції |
| L1 Capital International Pty Ltd | $46 121 648 | 118 294 | 0,12% | Акції |
| FIRST TRUST ADVISORS LP | $44 251 579 | 113 498 | 0,11% | Акції |
| PFA Pension, Forsikringsaktieselskab | $44 046 098 | 112 971 | 0,11% | Акції |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $43 830 264 | 112 417 | 0,11% | Акції |
| EP Wealth Advisors, LLC | $43 287 826 | 111 026 | 0,11% | Акції |
| WOLVERINE TRADING, LLC | $42 597 104 | 101 200 | 0,11% | Опціон кол |
| MERCER GLOBAL ADVISORS INC /ADV | $42 302 070 | 108 497 | 0,11% | Акції |
Інсайдери компанії 91 інсайдер · 54 керівники · 31 директори
| Інсайдер | Роль | Остання активність | Кількість акцій у власності | Купівлі за 12 міс. | Продажі за 12 міс. | Нетто 12 міс |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10 лютого 2026 р. F | 64 842 | 0 | 7 | $-21 483 290 |
| O'Boyle Michael P | President & CEO - Parallon | 26 лютого 2013 р. A | 21 429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 07 травня 2026 р. G | 46 576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16 лютого 2024 р. F | 22 251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17 листопада 2006 р. D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17 листопада 2006 р. D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17 листопада 2006 р. D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 01 липня 2005 р. F | 13 865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12 листопада 2024 р. M | 6 843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31 липня 2024 р. M | 27 008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16 лютого 2024 р. F | 17 936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11 листопада 2022 р. M | 202 443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11 листопада 2022 р. S | 30 807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31 грудня 2012 р. A | 335 657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 02 листопада 2011 р. M | 144 714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26 липня 2006 р. A | 62 173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27 жовтня 2005 р. A | 26 154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31 жовтня 2004 р. D | 9 029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 07 травня 2004 р. D | 24 177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10 лютого 2026 р. F | 23 062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 13 лютого 2026 р. M | 8 853 | 0 | 2 | $-2 747 520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11 лютого 2026 р. S | 11 993 | 0 | 2 | $-4 126 932 |
| Christopher F. Wyatt | SVP & Controller | 11 лютого 2026 р. S | 44 379 | 0 | 1 | $-2 020 000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10 лютого 2026 р. F | 10 407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10 лютого 2026 р. F | 32 080 | 0 | 1 | $-747 135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13 лютого 2025 р. F | 11 113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14 листопада 2024 р. S | 9 454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12 листопада 2024 р. M | 52 702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 05 серпня 2024 р. G | 18 526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29 липня 2024 р. S | 3 510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 липня 2024 р. S | 17 755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 09 травня 2024 р. S | 5 185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18 березня 2024 р. M | 1 576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12 квітня 2023 р. M | 24 643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 09 листопада 2021 р. S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 05 травня 2021 р. S | 50 062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18 лютого 2021 р. F | 5 578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18 лютого 2021 р. F | 10 122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 01 травня 2019 р. A | 194 145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25 лютого 2019 р. M | 84 157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25 лютого 2019 р. M | 881 823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25 лютого 2018 р. M | 7 003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25 лютого 2018 р. M | 35 546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25 лютого 2018 р. M | 65 199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23 травня 2017 р. M | 26 378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 07 листопада 2016 р. M | 110 167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25 лютого 2016 р. A | 51 965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16 травня 2012 р. M | 299 030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 06 жовтня 2009 р. A | 188 340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27 лютого 2009 р. M | 13 092 | 0 | 0 | $0 |
Інсайдери згідно з формами SEC 3/4/5; чистий результат = лише відкритий ринок купівлі/продажу
Активісти та власники %+ 5 4 холдинги
Інвестори, які подали Розклад SEC 13D — бенефіціарна власність понад 5% з наміром вплинути на емітента (активістські частки, кампанії в раді директорів, M&A). Кожен рядок показує останній відомий стан позиції цього подавця.
| Подавець | Подано | Частка | Статус | Мета | Подача |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10 лютого 2026 р. | 31,60% | Первинна подача | — | SEC |
| 22 листопада 2006 р. | — | Первинна подача | — | SEC | |
| Merrill Lynch Bank USA | 11 вересня 2006 р. | — | Первинна подача | — | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 04 серпня 2006 р. | — | Первинна подача | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Присутність в ETF Належить 207 ETF
Вага відображає лише прямі акціонерні володіння (N-PORT); фонди з кредитним плечем або похідними інструментами можуть мати додаткову експозицію за свопами, яка не відображається.
| Фонд | Вага | Одиниці | Станом на | Джерело |
|---|---|---|---|---|
| IHF · iShares Trust | 4,67% | 141 320 SH | 08 серпня 2026 р. | Щоденно |
| BUL · Pacer Funds Trust | 3,91% | 11 437 NS | 30 квітня 2026 р. | N-PORT |
| YALL · Tidal Trust I | 3,61% | 9 261 NS | 31 травня 2026 р. | N-PORT |
| BWTG · ETF Opportunities Trust | 3,02% | 1 646 NS | 31 травня 2026 р. | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 2,32% | 99 335 SH | 08 серпня 2026 р. | Щоденно |
| ABIG · EA Series Trust | 2,00% | 2 938 NS | 29 травня 2026 р. | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,99% | 39 985 NS | 30 квітня 2026 р. | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,67% | 31 685 SH | 08 серпня 2026 р. | Щоденно |
| COWZ · Pacer Funds Trust | 1,64% | 688 264 NS | 30 квітня 2026 р. | N-PORT |
| QQWZ · Pacer Funds Trust | 1,64% | 1 762 NS | 30 квітня 2026 р. | N-PORT |
| FEGE · RBB Fund Trust | 1,46% | 74 706 NS | 31 травня 2026 р. | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 1,39% | 60 385 SH | 08 серпня 2026 р. | Щоденно |
| RPG · Invesco Exchange-Traded Fund Trust | 1,30% | 63 448 SH | 08 серпня 2026 р. | Щоденно |
| TMFE · RBB Fund, Inc. | 1,29% | 2 892 NS | 31 травня 2026 р. | N-PORT |
| AMID · EA Series Trust | 1,23% | 3 402 NS | 29 травня 2026 р. | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1,15% | 7 180 NS | 30 квітня 2026 р. | N-PORT |
| FMAG · FIDELITY COVINGTON TRUST | 1,12% | 6 544 NS | 30 квітня 2026 р. | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,12% | 73 639 NS | 30 квітня 2026 р. | N-PORT |
| SRHQ · Elevation Series Trust | 1,10% | 4 883 NS | 30 квітня 2026 р. | N-PORT |
| IYH · iShares Trust | 0,99% | 89 420 SH | 08 серпня 2026 р. | Щоденно |
| NEAR · iShares U.S. ETF Trust | 0,99% | 48 109 000 SH | 08 серпня 2026 р. | Щоденно |
| CURE · Direxion Shares ETF Trust | 0,98% | 3 122 NS | 30 квітня 2026 р. | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,90% | 470 451 SH | 08 серпня 2026 р. | Щоденно |
| NFRA · FlexShares Trust | 0,88% | 62 176 NS | 30 квітня 2026 р. | N-PORT |
| REVS · Columbia ETF Trust I | 0,87% | 5 693 NS | 30 квітня 2026 р. | N-PORT |
| RXL · ProShares Trust | 0,86% | 1 632 NS | 31 травня 2026 р. | N-PORT |
| DIVB · iShares Trust | 0,85% | 36 806 SH | 08 серпня 2026 р. | Щоденно |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,82% | 24 078 000 | 08 серпня 2026 р. | Щоденно |
| LSEQ · Harbor ETF Trust | 0,81% | 285 NS | 30 квітня 2026 р. | N-PORT |
| IXJ · iShares Trust | 0,80% | 81 465 SH | 08 серпня 2026 р. | Щоденно |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 26 493 000 | 08 серпня 2026 р. | Щоденно |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,74% | 2 335 SH | 08 серпня 2026 р. | Щоденно |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,73% | 21 329 NS | 30 квітня 2026 р. | N-PORT |
| RFFC · ALPS ETF Trust | 0,68% | 533 NS | 31 травня 2026 р. | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,68% | 2 698 NS | 30 квітня 2026 р. | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,67% | 12 075 SH | 08 серпня 2026 р. | Щоденно |
| VCEB · VANGUARD WORLD FUND | 0,62% | 8 146 000 PA | 08 серпня 2026 р. | Щоденно |
| FDMO · FIDELITY COVINGTON TRUST | 0,61% | 11 771 NS | 30 квітня 2026 р. | N-PORT |
| RECS · Columbia ETF Trust I | 0,58% | 72 768 NS | 30 квітня 2026 р. | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,56% | 9 664 NS | 31 травня 2026 р. | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,55% | 11 876 SH | 08 серпня 2026 р. | Щоденно |
| VLLU · Harbor ETF Trust | 0,54% | 54 NS | 30 квітня 2026 р. | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,53% | 7 404 NS | 30 квітня 2026 р. | N-PORT |
| WLDR · Two Roads Shared Trust | 0,51% | 844 NS | 30 квітня 2026 р. | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 0,50% | 4 620 NS | 31 травня 2026 р. | N-PORT |
| AKAF · ETF Series Solutions | 0,50% | 39 NS | 31 травня 2026 р. | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,50% | 22 679 000 | 08 серпня 2026 р. | Щоденно |
| ROUS · Lattice Strategies Trust | 0,47% | 6 388 NS | 30 квітня 2026 р. | N-PORT |
| VCLT · VANGUARD SCOTTSDALE FUNDS | 0,46% | 54 218 000 PA | 08 серпня 2026 р. | Щоденно |
| CGGR · Capital Group Growth ETF | 0,45% | 290 273 NS | 31 травня 2026 р. | N-PORT |